IMVT

Immunovant Inc. Common Stock (IMVT)

Stock · NASDAQ · Health Care

$41.2as of 8/28/2026

Active signals

No technical signal is currently active for this symbol.

Support level
$38
Industry
Biotechnology: Biological Products (No Diagnostic Substances)

About IMVT

Sector
Health Care
Industry
Biotechnology: Biological Products (No Diagnostic Substances)

Fundamentals

Market cap
$8.20B
P/E (trailing)
P/E (forward)
EPS (trailing)
$-2.81
Dividend yield
Beta
0.83
Avg. volume
52-week range
$14.47$45.42

Immunovant Inc. Common Stock Competitors

Chosen by industry and closest market cap.

  • IMVT
    Immunovant Inc. Common Stock
    $41.23
    ▼ 5.91%
    Market cap $8.20BP/E
    $14.47$45.42
  • QGEN
    Qiagen N.V. Common Shares
    $43.12
    ▼ 1.43%
    Market cap $8.60BP/E 22.14
    $32.53$57.82
  • KYMR
    Kymera Therapeutics Inc. Common Stock
    $118.08
    ▼ 1.79%
    Market cap $8.75BP/E
    $39.84$130.05
  • TWST
    Twist Bioscience Corporation Common Stock
    $141.16
    ▼ 7.80%
    Market cap $6.84BP/E
    $23.3$155.44
  • HALO
    Halozyme Therapeutics Inc. Common Stock
    $105.33
    ▼ 1.49%
    Market cap $10.17BP/E 27.63
    $61.23$109.66
  • CRSP
    CRISPR Therapeutics AG Common Shares
    $57.69
    ▼ 2.84%
    Market cap $4.99BP/E
    $44.12$78.48
  • RLAY
    Relay Therapeutics Inc. Common Stock
    $18.78
    ▼ 3.30%
    Market cap $3.78BP/E
    $3.5$21.27

P/E shows — for peers not currently carrying a live signal of their own.

Institutional Ownership

March 31, 2026

Total shares held
108.88M
Total value held
$2.60B
Institutional holders
210
Top holders this quarter
  • Unknown16.95M
  • Unknown11.53M
  • Unknown6.57M
  • Unknown5.46M
  • Unknown5.46M
  • Unknown4.54M
  • Unknown4.46M
  • Unknown3.88M
  • Unknown3.62M
  • Unknown3.61M

See the full, filterable feed with live charts on the MarketWall dashboard.

We use analytics to understand how market-wall is used. No personal data is sold.